Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesBioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp Common stock

Basic Materials Specialty Chemicals
PortfolioPortfolio WatchlistWatchlist
Company price
0.82 USD -0.07 ( 8.10%)
Last update at 2026-11-10T21:00:00Z
VOLUME
1854
Market Cap
5.51M

Momentum Score

…

BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It also develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.81
Low
0.86
High
52 Week Price Range
1.92
Low
15.60
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

BioNexus Gene Lab Corp is a Nasdaq-listed company for which public disclosures provide limited detail about core operations, product pipeline and commercial activities. The firm appears positioned in the genomics/biotech sector, and any progress in developing validated assays, research services or collaborations could support long-term growth and offer exposure to that industry.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.89
Dividend Yield
-
Revenue TTM
7.42M
Revenue Per Share
4.00
Gross Profit TTM
1.09M
Debt / Equity
0.02
ROE
-35.24%
Net Debt
-2.21M
ROCE
-33.96%
Diluted EPS TTM
-1.61

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -2.98M -1.59M -2.61M -0.30M 1.04M
Net income -2.98M -1.60M -2.63M -0.36M 0.75M
Selling general administrative 2.33M 1.97M 2.44M 1.73M 1.20M
Selling and marketing expenses 1.74M 2.03M 0.60M - -
Gross profit 1.09M 1.29M 1.33M 1.26M 2.19M
Reconciled depreciation 0.17M 0.15M 0.10M 0.11M 0.11M
Ebit -2.97M -1.57M -2.59M -0.29M 1.06M
Ebitda -2.80M -1.42M -2.49M -0.19M 1.16M
Depreciation and amortization 0.17M 0.15M 0.11M 0.11M 0.11M
Non operating income net other - - - - -0.23M
Operating income -3.16M -1.57M -2.59M -0.29M 1.06M
Other operating expenses 10.58M 11.08M 12.36M 11.22M 12.31M
Interest expense 0.02M 0.02M 0.01M 0.01M 0.01M
Tax provision 0.00M 0.00M 0.11M 0.05M 0.29M
Interest income 0.08M 0.15M 0.07M - -
Net interest income 0.06M 0.13M -0.01M -0.01M -0.01M
Income tax expense - 0.00M 0.02M 0.05M 0.29M
Total revenue 7.42M 9.51M 9.77M 10.93M 13.36M
Total operating expenses 4.24M 2.86M 3.92M 1.55M 1.14M
Cost of revenue 6.34M 8.22M 8.44M 9.67M 11.17M
Total other income expense net 0.17M -0.02M -0.01M -0.01M -0.01M
Net income from continuing ops -2.98M -1.60M -3.09M -0.36M 0.80M
Net income applicable to common shares - - - - 0.75M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 9.25M 10.43M 11.40M 8.74M 9.57M
Other current assets 1.74M 0.08M 0.12M 1.54M 0.07M
Total liab 0.64M 2.11M 1.74M 2.08M 2.39M
Total stockholder equity 8.61M 8.32M 9.66M 6.67M 7.18M
Other current liab 0.45M 0.30M 0.19M 0.10M 0.17M
Common stock 20.17M 17.33M 17.19M 10.93M 10.78M
Capital stock 20.17M 17.33M 17.19M 10.93M 10.78M
Retained earnings -6.43M -3.44M -1.84M 1.16M 1.51M
Other liab - - - - 0.03M
Cash 2.38M 4.38M 5.93M 2.12M 2.12M
Total current liabilities 0.52M 1.95M 1.63M 2.00M 2.33M
Current deferred revenue 0.01M 0.10M - 0.02M 0.11M
Net debt -2.21M -4.17M -5.80M -2.06M -2.05M
Short term debt 0.06M 0.05M 0.03M 0.02M 0.04M
Short long term debt total 0.18M 0.21M 0.13M 0.06M 0.08M
Other stockholder equity -5.01M -5.01M -6.86M -5.01M -5.01M
Property plant equipment - - - - 1.63M
Total current assets 5.45M 7.43M 8.05M 6.02M 7.15M
Long term investments 2.03M 1.27M 1.70M 1.15M 0.75M
Net tangible assets - - - - 7.18M
Short term investments - 2.79M 3.31M - -
Net receivables 0.65M 1.58M 0.98M 2.93M 3.44M
Inventory 0.68M 1.39M 1.14M 0.98M 1.52M
Accounts payable 0.00M 1.50M 1.40M 1.86M 2.01M
Accumulated other comprehensive income -0.12M -0.56M -0.68M -0.41M -0.10M
Common stock total equity - - - - 10.78M
Retained earnings total equity - - - - 1.51M
Non currrent assets other - - - - 0.79M
Non current assets total 3.80M 3.00M 3.35M 2.72M 2.42M
Capital lease obligations 0.18M 0.21M 0.13M 0.06M 0.08M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.96M 0.42M -0.42M -0.45M -0.51M
Change to liabilities - - - - -1.18M
Total cashflows from investing activities 0.94M 0.42M -1.86M - -0.49M
Net borrowings - - 0.00M - -0.00M
Total cash from financing activities 0.30M 0.14M 6.27M 0.12M -0.03M
Change to operating activities - - - - -0.06M
Net income -2.98M -1.60M -2.63M -0.36M 0.75M
Change in cash -0.40M -1.63M 3.81M -0.01M -0.66M
Begin period cash flow 2.89M 4.52M 2.12M 2.12M 2.79M
End period cash flow 2.49M 2.89M 5.93M 2.12M 2.12M
Total cash from operating activities -1.84M -2.23M -1.76M 0.54M 0.01M
Issuance of capital stock 0.27M 0.00M 5.75M 0.15M -
Depreciation 0.11M 0.15M 0.11M 0.11M 0.11M
Other cashflows from investing activities -0.04M 0.15M -1.41M - 0.02M
Dividends paid 0.02M 0.07M 0.12M -0.00M -0.02M
Change to inventory 0.71M -0.25M -0.16M 0.54M -0.35M
Change to account receivables 0.78M 0.15M 0.61M 0.54M 0.58M
Other cashflows from financing activities 0.03M 0.14M 0.52M 0.00M 0.02M
Change to netincome - - - - 0.00M
Capital expenditures 0.04M 0.23M 0.15M 0.05M 0.00M
Change receivables - - - - 0.58M
Cash flows other operating - - - - 0.07M
Cash and cash equivalents changes - - - - -0.51M
Change in working capital -0.62M 0.12M 0.12M 0.83M -0.86M
Stock based compensation 0.79M 0.14M 0.51M - -
Other non cash items 0.86M -0.90M 0.64M -0.04M 0.01M
Free cash flow -1.88M -2.46M -1.91M 0.49M 0.01M

Peer Comparison*

Sector: Basic Materials Industry: Specialty Chemicals

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BGLC
BioNexus Gene Lab Corp Common stock		 -0.07
8.10%		 0.82 - - 0.74 0.64 0.22 629.53
LIN
Linde plc Ordinary Shares		 2.44
0.47%		 522.76 33.77 28.90 6.56 5.42 7.03 18.92
AIQUY
Air Liquide SA ADR		 0.06
0.14%		 42.57 30.69 24.81 4.70 4.10 4.36 15.61
AIQUF
L'Air Liquide S.A		 -0.00
0.00%		 213.34 29.78 22.68 4.54 3.98 4.50 15.90
SHW
Sherwin-Williams Co		 -2.62
0.73%		 355.31 33.33 27.40 3.38 20.60 3.88 21.36

Profile*

BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It also develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Menara UOA Bangsar, Kuala Lumpur, Malaysia, 59000

60 1 307 241 6898

https://www.bionexusgenelab.com

19

Name Title Year Born
Ms. Wei Li Leong CFO & Principal Accounting Officer 1989
Mr. Liong Tai Tan COO & Exec. Director 1959
Mr. Sook Keng Yeoh CEO & Director 1958
Ms. Yee Meng Wong Pres & Director 1985
Dr. Choong-Chin Liew Co-Founder, Chief Scientist & Scientific Adviser 1938
Mr. Kwan Wah Chan Marketing Mang. NA
Mr. Too Kam Tham Managing Director NA
Mr. Su-Leng Tan CEO & Director 1984
Mr. Kwan Wah Chan Marketing Manager NA
Mr. Su-Leng Tan CEO, Acting CFO, Secretary & Director 1983

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…